Stay updated on Pembrolizumab vs Topotecan in Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Topotecan in Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab vs Topotecan in Small Cell Lung Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page now shows a new revision tag, v3.5.4, replacing the previous v3.5.3. This indicates a routine platform update rather than a modification to the study record itself.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page’s footer “Revision” value is updated from v3.5.2 to v3.5.3, indicating a minor website software/version update to how the history page is presented.SummaryDifference0.1%

- Check29 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.2%

- Check36 days agoChange DetectedDifference0.1%

- Check58 days agoChange Detected- Revision notes updated: v3.5.0 added and v3.4.3 removed from the record history.SummaryDifference0.1%

- Check94 days agoChange DetectedNew revision entry v3.4.2 is added to the history and the previous revision v3.4.1 is removed, a minor bookkeeping update to the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs Topotecan in Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Topotecan in Small Cell Lung Cancer Clinical Trial page.